Drug Shortage Report for ZEPZELCA
Report ID | 158388 |
Drug Identification Number | 02520834 |
Brand name | ZEPZELCA |
Common or Proper name | lurbinectedin |
Company Name | JAZZ PHARMACEUTICALS IRELAND LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | 4MG |
Dosage form(s) | POWDER |
Route of administration | INTRAVENOUS |
Packaging size | 1 vial |
ATC code | L01XX |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-04-30 |
Actual start date | |
Estimated end date | 2022-06-30 |
Actual end date | 2022-06-30 |
Shortage status | Resolved |
Updated date | 2022-08-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5TH FLOOR, WATERLOO EXCHANGE, WATERLOO RD. DUBLIN, DUBLIN IRELAND D04 E5W7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-08-03 | French | Compare |
v11 | 2022-07-01 | French | Compare |
v10 | 2022-06-30 | French | Compare |
v9 | 2022-06-30 | English | Compare |
v8 | 2022-06-30 | French | Compare |
v7 | 2022-06-30 | English | Compare |
v6 | 2022-05-01 | English | Compare |
v5 | 2022-04-19 | English | Compare |
v4 | 2022-04-08 | French | Compare |
v3 | 2022-04-08 | English | Compare |
v2 | 2022-04-08 | French | Compare |
v1 | 2022-04-08 | English | Compare |
Showing 1 to 12 of 12